HER2 copy number quantification in primary tumor and cell-free DNA provides additional prognostic information in HER2 positive early breast cancer

BACKGROUND: The quantitative relationship between HER2 copy number and prognosis in HER2 positive adjuvant setting remain controversial, and few studies have focused on adjuvant setting to illustrate the potential clinical relevance of HER2 in cfDNA. Our study aim to develop a novel method in HER2 q...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Xiaobin, Lin, Yuxiang, Jiang, Zhengwen, Li, Yan, Zhang, Yihua, Wang, Ying, Yu, Feng, Guo, Wenhui, Chen, Lili, Chen, Minyan, Zhang, Wenzhe, Wang, Chuan, Fu, Fangmeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8850316/
https://www.ncbi.nlm.nih.gov/pubmed/35158152
http://dx.doi.org/10.1016/j.breast.2022.02.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8850316/
https://www.ncbi.nlm.nih.gov/pubmed/35158152
http://dx.doi.org/10.1016/j.breast.2022.02.002

Ejemplares similares